Empowering Pharma with AI-Driven Clinical Evidence
RWEOne is a specialized clinical technology and services partner empowering global pharmaceutical companies to conduct end-to-end Real-World Evidence (RWE) and Real-World Data (RWD) studies. Backed by 12+ years of clinical expertise, RWEOne integrates artificial intelligence with existing healthcare data endpoints to compress clinical study lifecycles, validate data in real-time, and drive confident regulatory and commercial decisions.
Specialists in End-to-End Evidence Generation
RWEOne is more than a technology vendor — we are a specialized clinical technology and services partner dedicated to the global pharmaceutical industry. Our unique offering combines a purpose-built AI technology platform with deep in-house clinical operations, biostatistics, and regulatory expertise.
We focus exclusively on Real-World Evidence (RWE) and Real-World Data (RWD) studies across every phase of the product lifecycle — from early Phase 1 feasibility through post-market Phase 4 surveillance and lifecycle evidence generation.
The RWEOne platform delivers Electronic Data Capture (EDC) with dynamic eCRF building, CDISC/CDASH compliance by default, AI-driven data validation, RabbitMQ-based immutable audit trails, and real-time analytics — all in a single, unified ecosystem designed to eliminate vendor fragmentation.
Built to Deliver Trusted Evidence at Speed
Every study we run combines a mature global network, AI-driven technology, and a compliance-first architecture engineered for regulatory-grade results.
Expansive Global Site Network
Accelerate investigator onboarding and patient access. Tap into our established global connections across diverse therapeutic areas to capture high-fidelity, representative data.
AI-Powered Trial Acceleration
The future of pharma relies on speed without compromising accuracy. Our AI-driven validations automate the heaviest data burdens, reducing the time and cost of moving from Phase 1 to post-market Phase 4.
Uncompromising Compliance & Security
Stay audit-ready from day one. We ensure absolute data integrity with robust restricted sponsor access, digital CTA signatures, and immutable event tracking.
Unified, End-to-End Execution
Eliminate vendor fragmentation. From study design to advanced analytics, manage your entire RWE lifecycle within a single, interconnected ecosystem.
Principles That Guide Every Study We Run
Evidence First
Every decision is grounded in rigorous methodology and scientific integrity.
Compliance By Design
GxP, 21 CFR Part 11, GDPR — baked into every layer of our platform and process.
Speed Without Compromise
AI-driven workflows accelerate timelines while upholding the highest data quality standards.
Partner Mentality
We embed with your team — an extension of your clinical, medical, and commercial functions.
Over a Decade of Clinical Innovation
Founded
RWEOne established with a mission to transform real-world evidence generation for pharma.
RWEOne established with a mission to transform real-world evidence generation for pharma.
Global Expansion
Expanded site network across 30+ countries and launched proprietary eCRF platform.
Expanded site network across 30+ countries and launched proprietary eCRF platform.
AI Integration
First AI-driven validation engines deployed, reducing query resolution time by 60%.
First AI-driven validation engines deployed, reducing query resolution time by 60%.
RWD Lake Launch
Introduced comprehensive Real-World Data lake architecture for continuous evidence generation.
Introduced comprehensive Real-World Data lake architecture for continuous evidence generation.
500+ Studies Delivered
Celebrated 500+ successful studies and 50+ country coverage across all major therapeutic areas.
Celebrated 500+ successful studies and 50+ country coverage across all major therapeutic areas.
Seasoned Experts in Clinical & Regulatory Strategy
Our cross-functional leadership team combines decades of pharmaceutical industry experience across clinical operations, technology, biostatistics, and regulatory affairs.
Dr. Sarah Chen
Chief Executive Officer
MD, MPH — 20+ yrs pharma clinical strategy
James Whitmore
Chief Technology Officer
MS Computer Science — Ex-Oracle Health, EDC platform architect
Dr. Marcus Rivera
Chief Scientific Officer
PhD Biostatistics — Led 200+ Phase 1-4 studies
Elena Kowalski
Head of Regulatory Affairs
JD, Regulatory Law — 15+ yrs FDA/EMA submissions
Ready to modernize your clinical evidence strategy?
See how RWEOne can compress your trial timelines and automate your data workflows. Book a custom demo tailored to your therapeutic area and Phase 1-4 objectives.
What to expect on your demo:
- A live walkthrough of our dynamic eCRF builder.
- A showcase of our AI-driven validation engines in action.
- A tailored discussion on mapping your specific Phase 1-4 endpoints.
Request Your Platform Demo
Compliance-first.Every engagement is covered by mutual NDA. All data pipelines and platform workflows are validated for use in GxP and 21 CFR Part 11 contexts.